Biosimilars: achieving long-term savings and competitive markets
Author byline as per print journal: Jorge Mestre-Ferrandiz, PhD; Adrian Towse, MA; Mikel Berdud, PhD Abstract: Payers need to think strategically in medium/long term to maximize benefits from biosimilars. Concerns about biosimilars’ interchangeability/substitution (with their reference product) and uncertainty about outcomes act as barriers for their uptake. This paper recommends a policy which provides: (1) […]
